First Bard Hernia Mesh Trial Set To Begin May 11, 2020 in Federal MDL

The U.S. District Judge presiding over all Bard hernia mesh lawsuits has scheduled the first bellwether trial to begin on May 11, 2020, which will be closely watched to gauge how juries are likely to respond to certain evidence and testimony that may be repeated throughout thousands of claims brought nationwide.

Given common questions of fact and law raised in product liability complaints filed against C.R. Bard throughout the federal court system, there are currently more than 4,500 claims centralized before U.S. District Judge Edmund A. Sargus in the Southern District of Ohio, as part of a multidistrict litigation, or MDL.

Plaintiffs each allege that they were left with painful and debilitating complications after hernia repair involving Bard Ventralex, Bard Perfix, Bard Composix and other polypropylene mesh products sold in recent years.

Learn More About

Hernia Mesh Lawsuits

Cases reviewed for problems with several types of hernia repair products.

Learn More About this Lawsuit See if you qualify for a settlement

As part of the coordinated discovery and management of the Bard hernia mesh litigation, Judge Sargus has previously established a bellwether trial process, which will result in a series of three representative claims going before juries next year to help the parties evaluate the strengths and weaknesses of their positions, and facilitate potential settlement negotiations.

In an order (PDF) issued on December 12, Judge Sargus set the first Bard hernia mesh trial date for May 11, 2020, which is expected to be followed by additional trials in July and September 2020.

Leading up to the first bellwether trial, the parties will meet for two final pretrial conferences, including one that will be held on April 27 and a second two-day conference set for May 4-5. At those conferences, the court will resolve objections to exhibits and deposition designations, and establish rule on any pretrial motions.

While the outcome of the early trial dates will not be binding on other claims pending against Bard, they will be closely watched by the parties and may influence potential hernia mesh settlements that may avoid the need for thousands of individual claims to be set for trial in U.S. District Courts nationwide.

In addition to cases against Bard, similar allegations have also been raised in thousands of Atrium C-Qur lawsuits and Ethicon Physiomesh lawsuits, which involve competing hernia repair products that have also been linked to design problems that resulted in a high rate of failure.

Since most individuals are unaware of what type of product was used during a hernia repair, and mesh implanted in recent years continues to fail, it is widely expected that the size of the litigation will continue to grow over the next year.


"*" indicates required fields

Share Your Comments

I authorize the above comments be posted on this page*

Have Your Comments Reviewed by a Lawyer

Provide additional contact information if you want an attorney to review your comments and contact you about a potential case. This information will not be published.

NOTE: Providing information for review by an attorney does not form an attorney-client relationship.

This field is for validation purposes and should be left unchanged.

More Top Stories

Bard Argues Hernia Mesh Lawsuits Previously Selected for Bellwether Trials Are No Longer
Bard Argues Hernia Mesh Lawsuits Previously Selected for Bellwether Trials Are No Longer "Representative" (Posted 5 days ago)

Bard claims two cases selected for the third and fourth bellwether trials are no longer representative of the litigation due to the plaintiffs' worsening injuries and need for additional surgeries due to their failed hernia mesh products.